Next-Gen Heart Valve Design Platform
Valvular Heart Disease (Aortic/Mitral Valve Replacement)
Pre-clinicalActive
Key Facts
Indication
Valvular Heart Disease (Aortic/Mitral Valve Replacement)
Phase
Pre-clinical
Status
Active
Company
About ValTech Lifesciences
ValTech Lifesciences, founded in 2018 and based in Bern, Switzerland, is an early-stage innovator in the structural heart space. The company is developing a proprietary technology platform to enhance the design of heart valve prostheses, targeting key limitations of current devices such as thrombosis and durability. It operates as a B2B enabler, intending to license its patented designs to established valve prosthesis manufacturers. Currently in a pre-revenue, R&D-focused stage, the company is positioned to address a significant unmet need in the growing global heart valve market.
View full company profile